By Gina Shaw
CVS Health removed five drugs from its formulary in April 2019 and replaced them with lower-cost alternatives, part of a “hyperinflation” cost containment strategy that focuses on excluding drugs that see high price inflation or have dramatically higher prices compared with clinically equivalent alternatives.
AUGUST 28, 2019